Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Ottawa

$378,676.00

Machine M.D.: How Should We Regulate AI in Health Care?

FY 2020-21

Summary
Advocates argue that artificial intelligence (AI) technologies will transform health care for the better by, e.g., reducing high levels of medical error that occur within hospitals. However, there are also many concerns. For example, can a surgeon obtain "informed" consent from a patient if the surgeon does not understand how AI makes its decision? Who should be held to account, and for what, when injury arises from the use of AI? How can we prevent "algorithmic bias," which is when AI products discriminate because the data they are built upon are under-representative of, e.g., women, Indigenous Peoples or Black Canadians? And will patient privacy be jeopardized as AI tools process huge quantities of personal health information and share that data with others? We do not yet know whether Canada's complex web of uncoordinated laws and regulations will adequately protect patients and other users against potential problems with AI in health care. Our multidisciplinary research team will rigorously assess 10-12 AI case studies in different care settings, representative of the potential risks of AI in health care. We will use a case study method to scrutinize the sufficiency of legal governance of current and emerging AI technologies in the Canadian system and in selected foreign jurisdictions. This will enable us to clearly identify where there are gaps in existing legal protections and if law reform is required, whether that be changes to existing laws or ethical codes, or entirely new laws. To generate the best advice on law reform options, we will work closely not only with AI innovators and health care providers that are part of our research team, but also with key decision-makers, like Health Canada, and with patient representatives. Our goal is for Canadian patients and society to truly benefit from the revolutionary potential of AI in health. This will require optimal regulation of heath care, which is as important as the health innovation itself.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
434862
Name
Flood Colleen M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Humanities, Social Sciences, Law & Ethics in Health
Projecttitle
Machine M.D.: How Should We Regulate AI in Health Care?
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$378,676
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Artificial Intelligence; Health Information Privacy; Health Law And Policy; Machine Learning; Medical Devices Regulation; Patient Safety
Abstract
Advocates argue that artificial intelligence (AI) technologies will transform health care for the better by, e.g., reducing high levels of medical error that occur within hospitals. However, there are also many concerns. For example, can a surgeon obtain "informed" consent from a patient if the surgeon does not understand how AI makes its decision? Who should be held to account, and for what, when injury arises from the use of AI? How can we prevent "algorithmic bias," which is when AI products discriminate because the data they are built upon are under-representative of, e.g., women, Indigenous Peoples or Black Canadians? And will patient privacy be jeopardized as AI tools process huge quantities of personal health information and share that data with others? We do not yet know whether Canada's complex web of uncoordinated laws and regulations will adequately protect patients and other users against potential problems with AI in health care. Our multidisciplinary research team will rigorously assess 10-12 AI case studies in different care settings, representative of the potential risks of AI in health care. We will use a case study method to scrutinize the sufficiency of legal governance of current and emerging AI technologies in the Canadian system and in selected foreign jurisdictions. This will enable us to clearly identify where there are gaps in existing legal protections and if law reform is required, whether that be changes to existing laws or ethical codes, or entirely new laws. To generate the best advice on law reform options, we will work closely not only with AI innovators and health care providers that are part of our research team, but also with key decision-makers, like Health Canada, and with patient representatives. Our goal is for Canadian patients and society to truly benefit from the revolutionary potential of AI in health. This will require optimal regulation of heath care, which is as important as the health innovation itself.
Competitiondate
202010
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Flood, Colleen M; Goldenberg, Anna; Regis, Catherine; Scassa, Teresa
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $378,676~ $0~